arthropodborn
flavivirus
genu
flaviviru
famili
flavivirida
includ
human
pathogen
global
medic
import
dengu
viru
denv
yellow
fever
viru
yfv
west
nile
viru
wnv
japanes
enceph
viru
jev
zika
viru
zikv
kyasanur
forest
diseas
viru
kfdv
omsk
hemorrhag
fever
viru
ohfv
tickborn
enceph
viru
tbev
virus
caus
mani
seriou
diseas
broad
spectrum
clinic
symptom
rang
near
asymptomat
mild
flulik
infect
neurolog
diseas
wnv
tbev
viscerotrop
denv
hemorrhag
kfdv
ohfv
even
terratogen
manifest
zikv
million
new
case
infect
caus
arthropodborn
flavivirus
report
annual
virus
widespread
exemplifi
epidemiolog
outbreak
wnv
infect
across
north
america
mexico
south
america
caribbean
zikv
infect
oceania
latin
america
present
effect
antivir
therapi
direct
virus
therefor
search
small
moleculebas
inhibitor
repres
unmet
medic
need
arbidol
also
known
umifenovir
broadspectrum
antivir
compound
develop
russian
research
chemic
pharmaceut
institut
year
ago
licens
russia
china
prophylaxi
treatment
human
influenza
b
infect
plu
postinfluenza
complic
subsequ
arbidol
shown
activ
numer
dnarna
envelopednonenvelop
virus
predomin
mode
action
arbidol
base
intercal
membran
lipid
lead
inhibit
membran
fusion
viru
particl
plasma
membran
viru
particl
membran
endosom
influenza
viru
arbidol
observ
interact
viru
hemagglutinin
ha
caus
increas
ha
stabil
therebi
prevent
phinduc
transit
ha
function
fusogen
state
case
hepat
c
viru
hcv
arbidol
interact
hcv
envelop
protein
caus
variou
degre
inhibit
critic
membran
fusion
event
altern
arbidol
may
also
immunomodulatori
capabl
interferon
induct
andor
macrophag
activ
due
broadspectrum
antivir
activ
arbidol
repres
promis
candid
treatment
viral
infect
human
accordingli
describ
use
standard
vitro
assay
system
cytotox
antivir
activ
arbidol
three
repres
flavivirus
zikv
wnv
emerg
mosquitoborn
pathogen
tbev
import
tickborn
pathogen
sinc
antivir
compound
extens
inactivatedmetabol
intracellular
environ
differ
cell
line
util
assess
simultan
antivir
correspond
cytotox
effect
arbidol
arbidol
dimethylamino
methyl
phenylthio
methyl
hydrochlorid
monohydr
figur
obtain
sigmaaldrich
st
loui
mo
usa
solubil
dmso
yield
mm
stock
solut
follow
viral
strainsisol
use
studi
zikv
repres
african
zikv
lineag
member
asian
zikv
lineag
wnv
strain
tbev
strain
hypr
typic
repres
west
european
tbev
subtyp
zikv
wnv
tbev
neurotrop
virus
cell
line
neuron
well
extraneur
origin
select
antivir
screen
viru
multipl
plaqu
assay
porcin
kidney
stabl
ps
cell
cultur
leibovitz
medium
human
brain
cortic
astrocyt
hbca
sciencel
carlsbad
ca
usa
cultiv
astrocyt
medium
thermo
fisher
scientif
weltham
usa
human
neuroblastoma
cell
cultur
iscov
modifi
dulbecco
medium
imdm
vero
cell
atcc
african
green
monkey
adult
kidney
epitheli
human
hepatocellular
carcinoma
cell
grown
dulbecco
modifi
eagl
medium
dmem
media
supplement
astrocyt
medium
imdm
dmem
newborn
calf
serum
mixtur
antibiot
antimycot
glutamin
sigmaaldrich
pragu
czech
republ
compound
cytotox
determin
term
cell
viabil
use
cell
count
dojindo
molecular
technolog
munich
germani
accord
manufactur
instruct
express
cytotox
concentr
repres
concentr
compound
reduc
cell
viabil
viral
titer
reduct
assay
perform
determin
flaviviru
sensit
arbidol
cell
cultur
host
cell
seed
plate
approxim
cell
per
well
incub
h
form
confluent
monolay
medium
aspir
well
replac
fresh
medium
contain
hbca
ps
vero
arbidol
incub
h
concentr
rang
base
differ
cytotox
effect
arbidol
individu
cell
line
describ
medium
remov
well
replac
fresh
medium
contain
arbidol
appropri
viru
strain
multipl
infect
moi
h
incub
medium
replac
fresh
medium
contain
arbidol
incub
h
supernat
medium
collect
viral
titer
determin
plaqu
assay
express
pfuml
use
construct
doserespons
inhibit
curv
estim
effect
concentr
construct
growth
curv
vero
cell
infect
describ
treat
arbidol
concentr
supernat
media
collect
everi
six
hour
h
pi
viral
titer
supernat
determin
use
plaqu
assay
experi
dmso
ad
virusinfect
cell
neg
control
concentr
correspond
dilut
initi
arbidoldmso
stock
cellbas
flaviviru
immunostain
assay
perform
measur
arbidolinduc
inhibit
viral
surfac
antigen
e
protein
express
previous
describ
differ
viral
titer
group
evalu
unpair
parametr
twotail
ttest
use
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
usa
version
differ
p
consid
statist
signific
initi
determin
arbidol
cytotox
profil
vero
ps
hbca
cell
appar
figur
arbidol
differenti
cytotox
lowest
cytotoxicit
observ
vero
cell
level
cytotox
time
lower
observ
cell
suscept
cell
studi
experi
cell
type
name
ps
hbca
gave
rise
valu
rang
tabl
variabl
cytotox
effect
arbidol
may
relat
broadspectrum
activ
impair
crucial
cellular
metabol
pathway
critic
step
viruscel
interact
contrast
antivir
drug
preferenti
target
viral
protein
nucleosid
inhibitor
viral
polymeras
valu
usual
exceed
typic
antivir
effect
arbidol
two
zikv
strain
evid
vero
hbca
cell
h
infect
wherea
hbca
highest
arbidol
concentr
test
caus
reduct
zikv
titer
compar
situat
mocktreat
cell
vero
cell
viral
replic
inhibit
complet
zikv
replic
inhibit
ps
cell
suggest
antivir
effect
arbidol
strongli
cell
typedepend
figur
phenomenon
describ
previous
mani
antivir
compound
thought
aris
differ
express
level
intracellular
enzymesprotein
involv
metabol
transport
differ
appar
ensur
inhibitor
exhibit
differ
valu
accord
cell
line
employ
exampl
sofosbuvir
found
differenti
activ
zikv
infect
depend
cultiv
cell
use
owe
differ
intracellular
process
base
result
evalu
inhibitori
potenti
arbitol
viral
infect
vero
cell
particular
instanc
valu
zikv
infect
vero
cell
found
respect
strain
figur
e
tabl
antivir
effect
arbidol
confirm
immunofluoresc
stain
use
method
dosedepend
inhibit
zikv
surfac
e
antigen
express
observ
vero
cell
figur
observ
antizikv
properti
compar
previous
report
smallmolecul
nucleosid
analogu
known
exert
antizikv
inhibit
micromolar
rang
accord
cellbas
assay
system
use
arbidol
also
show
signific
vitro
antivir
efficaci
test
two
strain
wnv
zikv
antiwnv
effect
arbidol
obviou
incub
wnvinfect
hbca
vero
cell
h
contrast
littl
antivir
effect
observ
ps
viru
infect
cell
figur
valu
vero
cell
found
respect
valu
slightli
higher
twotim
comparison
valu
found
zikv
figur
e
tabl
observ
arbidolmedi
decreas
wnv
titer
strongli
correl
dosedepend
inhibit
viral
surfac
e
antigen
express
compoundtr
vero
cell
cultur
figur
final
tbev
strain
hypr
infect
hbca
vero
cell
figur
also
prove
suscept
arbidolmedi
inhibit
dosedepend
manner
shown
valu
figur
e
tabl
howev
arbidol
introduc
highest
appropri
concentr
hbca
vero
cell
inhibit
tbev
replic
remain
incomplet
cell
cultur
although
viral
titer
reduc
compar
nontreat
cell
figur
figur
vero
cell
arbidol
administr
found
inhibit
viral
replic
case
fact
rapid
reduct
viral
titer
observ
within
first
h
pi
titer
remain
low
even
detect
limit
end
experi
untreat
cell
peak
viru
product
h
pi
reach
maximum
pfuml
supplementari
figur
data
agre
numer
report
vitro
arbidolmedi
inhibit
virus
medic
interest
arbidol
inhibit
replic
variou
subtyp
human
influenza
b
virus
valu
rang
arbidol
also
known
inhibit
chikungunya
viru
replic
vero
cell
primari
human
fibroblast
valu
plu
inhibit
crimeancongo
hemorrhag
fever
viru
replic
valu
furthermor
treatment
human
hepatocellular
carcinoma
cell
huh
arbidol
h
h
led
inhibit
hcv
replic
overal
arbidol
exhibit
broad
rang
antivir
effect
respiratori
syncyti
viru
hepat
b
viru
adenoviru
parainfluezna
viru
avian
coronaviru
coxacki
viru
hantaan
viru
indic
broadspectrum
antivir
activ
besid
vitro
studi
arbidol
also
exert
substanti
antivir
effect
variou
anim
model
infect
use
effect
clinic
trial
prevent
treatment
influenza
conclus
demonstr
arbidol
substanti
antivir
activ
zikv
wnv
tbev
vitro
valu
rang
observ
antivir
effect
strongli
celltyp
depend
substanti
hbca
vero
cell
arguabl
cell
line
variabl
result
differ
arbitol
uptak
metabol
process
differ
individu
cell
line
concern
arbidolmedi
cytotox
also
cell
line
depend
cell
suscept
vero
cell
least
data
broaden
possibl
futur
vivo
test
arbidol
anim
model
flaviviru
infect
